Skip to main
SYK
SYK logo

Stryker (SYK) Stock Forecast & Price Target

Stryker (SYK) Analyst Ratings

Based on 38 analyst ratings
Buy
Strong Buy 32%
Buy 42%
Hold 24%
Sell 3%
Strong Sell 0%

Bulls say

Stryker's positive outlook is bolstered by an increase in FY24 cash from operations to $4.2 billion, demonstrating a year-over-year growth of $531 million primarily due to higher earnings and improved inventory management. The company has seen significant growth in key segments such as Instruments and Endoscopy, driven by strong sales across their diverse product offerings, including innovative technologies like the Mako platform and the recent LIFEPAK 35 defibrillator. Additionally, Stryker maintains its market-leading position in reconstructive orthopedic implants and showcases ongoing strength in its Knee and Neurovascular segments, which further reinforces its competitive standing in the medical equipment industry.

Bears say

The analysis identifies several fundamental concerns impacting Stryker's stock outlook, primarily revolving around anticipated declines in elective procedures and hospital capital spending, which could lead to a 1% unfavorable effect on their FY25 revenue. Additionally, the company faces significant inflationary pressures that are expected to compress margins, alongside risks stemming from a challenging global healthcare environment exacerbated by COVID-19 disruptions and broader economic volatility. With projected limited margin expansion and potential pricing declines in the orthopedic sector, Stryker may struggle to achieve its long-term earnings growth targets, particularly as cash reserves decrease while facing risks associated with mergers, product launches, and market dynamics.

Stryker (SYK) has been analyzed by 38 analysts, with a consensus rating of Buy. 32% of analysts recommend a Strong Buy, 42% recommend Buy, 24% suggest Holding, 3% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Stryker and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Stryker (SYK) Forecast

Analysts have given Stryker (SYK) a Buy based on their latest research and market trends.

According to 38 analysts, Stryker (SYK) has a Buy consensus rating as of Jul 10, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $336.29, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $336.29, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Stryker (SYK)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.